Skip to content

Medial Border of Laparoscopic D3 Lymphadenectomy for Right Colon Cancer

the Medial Border Along the Left Side of SMA Versus the Left Side of SMV in Laparoscopic D3 Lymphadenectomy for Right Colon Cancer, a Prospective Cohort Study

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04518449
Enrollment
0
Registered
2020-08-19
Start date
2022-12-01
Completion date
2025-10-31
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer

Brief summary

This study investigats the gastrointestinal functional outcomes of laparoscopic D3 lymphadenectomy for right colon cancer with the medial border along the left side of superior mesenteric artery (SMA) versus the left side of superior mesenteric vein (SMV). This is a single center, prospective cohort study with a sample size of 264 patients. The primary endpoint is the incidence of diarrhea (evaluated using the Diarrhea Assessment Scale) one month after surgery.

Interventions

PROCEDUREmedial border along the left side of SMA

to place the medial border along the left side of SMA in laparoscopic D3 lymphadenectomy for right colon cancer

PROCEDUREmedial border along the left side of SMV

to place the medial border along the left side of SMV in laparoscopic D3 lymphadenectomy for right colon cancer

Sponsors

Shanghai Minimally Invasive Surgery Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years

Inclusion criteria

* Age between 18 and 75 years * American Society of Anesthesiologists (ASA) score I to III * A biopsy proven histological diagnosis of colorectal carcinoma * tumor located at right half of colon * Undergoing laparoscopic right hemi-colectomy * preoperative staging cT2-4aN0M0 or cTanyN+M0 * willing to participate and informed consent signed

Exclusion criteria

* Pregnant or lactating women * Synchronous colorectal carcinoma * History of colorectal cancer or other malignant tumors * Clinical evidence of metastasis * Preoperative staging cT1N0 or cT4bNany * Emergency procedure

Design outcomes

Primary

MeasureTime frameDescription
incidence of diarrheaone month after surgeryDiarrhea Assessment Scale: stool score ≥ 5

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026